Navigation Links
Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability
Date:1/18/2008

ATLANTA, Jan. 18 /PRNewswire/ -- Elekta, a world leader in clinical solutions for radiation therapy and radiosurgery, announced today that two sites are utilizing Elekta technology to implement clinical treatments with Volumetric Modulated Arc Therapy (VMAT)*. With the recent CE designation of VMAT in Europe, the way has been cleared for The Royal Marsden Hospital in Sutton, UK and General Hospital Vienna in Austria to treat cancer using Elekta's VMAT solution.

VMAT is a significant improvement to existing advanced radiation therapy techniques, often referred to as IMRT (Intensity Modulated Radiation Therapy) and offers a faster alternative to helical tomotherapy. With Elekta's VMAT technology, the target continuously is radiated while the source of the beam is rotated around the patient in single or multiple arcs. By simultaneously controlling gantry position, gantry speed, leaves of the multi-leaf collimator (MLC), collimator angle and dose rate, a highly conformal dose distribution is created in significantly less time than with today's techniques. With VMAT from Elekta, a treatment session typically can be conducted in five minutes or less, including true 3D imaging to secure the location of the target.

"VMAT is a very promising technique," says Dietmar Georg, Ph.D., head of the Division of Medical Radiation Physics, Department of Radiotherapy, Medical University Vienna/General Hospital Vienna. "The rotational therapy and intensity modulation results in improved dose distribution and high conformality for optimal sparing of normal tissue." Using VMAT, Dr. Georg expects to see a more efficient workflow and faster treatments for patients receiving advanced radiotherapy.

Jim Warrington, head of Radiotherapy Physics at The Royal Marsden Hospital, says, "With the potential to produce megavoltage X-ray treatments of the highest quality and efficiency available, we anticipate VMAT will offer us greater flexibility as a radiotherapy treatment
'/>"/>

SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Elekta Announces Clinical Start-up of Elekta Synergy(R) S at UPMC
2. Elekta Negotiates To Acquire CMS
3. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
4. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
5. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
6. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
7. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
8. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
9. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
10. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
11. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Rootstown, OH (PRWEB) January 22, 2015 Crystal ... announced today that it has received AOAC-PTM Certifications for the ... O111, O121, and O145; collectively referred to as STEC or ... at 1 colony forming unit (cfu) per 325 g of ...
(Date:1/22/2015)... 22, 2015 zFlo Motion , a ... announce an exciting product from a new partner. STT-Systems ... over the past 15 years, with offerings in the optical-motion ... 3D IMU system (inertial measurement unit), iSen, is opening eyes ...
(Date:1/22/2015)... DE (PRWEB) January 22, 2015 Controlled ... Pistoia Alliance, which helps companies check the legal requirements ... to expand to China. , As their international ... are globally adopting software solutions built as a result ...
(Date:1/22/2015)... 22, 2015 Diagenode, Inc., a ... the Bioruptor® and complete solutions for epigenetics research, ... immunoprecipitation, alleviating the need for manual processing. The ... for ChIP of histones or transcription factors and ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 23D Motion Capture Just Got Easy 2Global Compliance Service for Controlled Substances to Expand to China 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... BioTrends Research Group, Inc. finds that with ... (DMA) for the treatment of multiple sclerosis (MS), neurologists anticipate ... month after the launch of Gilenya, trial and uptake of ... to be tempered due to the perception that Extavia is ...
... , Menlo Park, Calif. December 9, 2010 ... and Harvard Medical School have successfully employed single molecule, ... pathogen responsible for the recent deadly cholera epidemic in ... Journal of Medicine, the results provide the first ...
... Dec. 10, 2010 ACCESS PHARMACEUTICALS, INC. ... biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments ... entered into definitive agreements with existing and new accredited investors ... approximately 2.3 million shares of its common stock at a ...
Cached Biology Technology:With the Recent Launch of Novartis's Gilenya, Extavia is Pushed Into the Background of Multiple Sclerosis Treatment One Year After its Launch 2With the Recent Launch of Novartis's Gilenya, Extavia is Pushed Into the Background of Multiple Sclerosis Treatment One Year After its Launch 3Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen 2Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen 3Access Pharmaceuticals Raises $6.0 Million In Registered Direct Offering 2Access Pharmaceuticals Raises $6.0 Million In Registered Direct Offering 3
(Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
(Date:1/22/2015)... Jan. 15, 2015  BellBrook Labs, a leader in ... the launch of a TR-FRET (time resolved Forster ... UDP Assay, a high throughput screening assay for ... will allow for sensitive detection of hundreds of ...
(Date:1/22/2015)... NEW YORK and POINT ROBERTS, Washington ... global news source covering leading sectors including technology and tech ... Personal Privacy marketplace featuring master pickpocket and security consultant ... wallet is stolen and talks about the Wocket™ biometric smart ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... gene therapy can nearly eliminate arthritis pain, and significantly ... a study published today in the journal Arthritis and ... are the first genetically engineered to develop osteoarthritis like ... more likely to develop the disease, the authors said. ...
... their brains are more adept at learning than their normal ... has changed, a team led by researchers at UT Southwestern ... today in the online edition of the journal Nature ... brain, which might serve in humans as a target for ...
... ants in the rainforests of Central and South America conduct ... some ants use their bodies to plug potholes in the ... so that prey can be delivered to the developing young ... the nest by a trail of forager traffic, along which ...
Cached Biology News:Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 3Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 4'Smart' mice teach scientists about learning process, brain disorders 2Ants show us how to make super-highways 2
14-3-3 tau Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Rabbit polyclonal to Lck (phospho Y192) ( Abpromise for all tested applications). entrezGeneID: 3932 SwissProtID: P06239...
Goat polyclonal to Ephrin B2 ( Abpromise for all tested applications). entrezGeneID: 1948 SwissProtID: P52799...
Mouse monoclonal [RL13] to LAP1 ( Abpromise for all tested applications). SwissProtID: Q96NW7...
Biology Products: